(Q28594979)

1 February 2017

title

Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility (English)

1 reference

Transforming growth factor, beta receptor III

1 February 2017

main subject

1 reference

GOA release 2020-03-11

1 reference

2

Carlos L. Arteaga

1 reference

1 February 2017

Tracy L. Criswell

1

1 reference

1 February 2017

language of work or name

English

0 references

publication date

2 November 2007

1 reference

Journal of Biological Chemistry

1 February 2017

published in

1 reference

1 February 2017

volume

282

1 reference

1 February 2017

issue

44

1 reference

1 February 2017

page(s)

32491–32500

1 reference

TGF-beta signal transduction

1 February 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Betaglycan presents ligand to the TGF beta signaling receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

The type III TGF-beta receptor suppresses breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Unraveling signalling cascades for the Snail family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Using three-dimensional acinar structures for molecular and cell biological assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

DNA array analysis of the developing rat cerebellum: transforming growth factor-beta2 inhibits constitutively activated NF-kappaB in granule neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

TGFBR3 loss and consequences in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Slug is an essential target of TGFbeta2 signaling in the developing chicken heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Metastasis is driven by sequential elevation of H-ras and Smad2 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Invasion and metastasis of a mammary tumor involves TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M704434200

21 January 2018

Identifiers

DOI

10.1074/JBC.M704434200

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017